Effects of electronic cigarettes on the liver (literature review)
https://doi.org/10.36604/1998-5029-2025-96-154-163
Abstract
At present, the impact of electronic cigarettes on human health is being actively investigated. The liver is a vital multifunctional organ whose function can be impaired by various toxic factors such as alcohol or traditional cigarette smoking. In this review, we examine and synthesize current scientific literature on the effects of electronic cigarettes on the liver, drawing on publications retrieved through Google Scholar, Elsevier, and PubMed. The review discusses how certain chemicals found in e-cigarette liquids and their derivatives act on the liver, the relationship between e-cigarette use and oxidative-stress parameters, their influence on mitochondria, and changes in organ-specific enzymes that serve as biomarkers of liver injury. Histopathological alterations detected in liver tissue after exposure to electronic cigarettes are described, and differences between nicotine-containing and nicotine-free e-liquids are considered. The possible role of vaping in the development of liver diseases in humans including acute non-infectious toxic hepatitis and non-alcoholic fatty liver disease is explored. On the basis of available scientific evidence, we conclude that electronic cigarettes are not harmless and exert a significant negative effect. At the same time, further studies on the impact of electronic cigarettes on the liver and other organs and systems are warranted.
About the Authors
O. G. AndrosovaRussian Federation
Olga G. Androsova, PhD (Med.), Associate Professor
Department of Physiology and Pathophysiology
675000; 95 Gor'kogo Str.; Blagoveshchensk
D. R. Allazov
Russian Federation
Dmitriy R. Allazov, 3rd year Student
Medical Faculty
675000; 95 Gor'kogo Str.; Blagoveshchensk
M. S. Zinin
Russian Federation
Maxim S. Zinin, 3rd year Student
Medical Faculty
675000; 95 Gor'kogo Str.; Blagoveshchensk
References
1. Perera S.D., Dulmini A.D.T. Overview of e-cigarettes and e-liquids. Rajarata University Journal 2022; 7(1):30–35.
2. Ali N., Xavier J., Engur M., Mohanah P.V., Bernardino de la Serna J. The impact of e-cigarette exposure on different organ systems: a review of recent evidence and future perspectives. J. Hazard. Mater. 2023; 457:131828. doi: 10.1016/j.jhazmat.2023.131828
3. Marques P., Piqueras L., Sanz M.J. An updated overview of e-cigarette impact on human health. Respir. Res. 2021; 22(1):151. doi: 10.1186/s12931-021-01737-5
4. Gotts J.E., Jordt S.E., McConnell R., Tarran R. What are the respiratory effects of e-cigarettes? BMJ 2019; 366:l5275. Erratum in: BMJ. 2019; 367:l5980. doi: 10.1136/bmj.l5275
5. Miyashita L., Foley G. E‐cigarettes and respiratory health: the latest evidence. J. Physiol. 2020; 598(22):5027–5038. doi: 10.1113/JP279526
6. Wang L., Wang Y., Chen J., Liu P., Li M. A review of toxicity mechanism studies of electronic cigarettes on respiratory system. Int. J. Mol. Sci. 2022; 23(9):5030. doi: 10.3390/ijms23095030
7. Benowitz N.L., Fraiman J.B. Cardiovascular effects of electronic cigarettes. Nat. Rev. Cardiol. 2017; 14(8):447–456. doi: 10.1038/nrcardio.2017.36
8. Qasim H., Karim Z.A., Rivera J.O., Khasawneh F.T., Alshbool F.Z. Impact of electronic cigarettes on the cardiovascular system. J. Am. Heart Assoc. 2017; 6(9):e006353. doi: 10.1161/JAHA.117.006353
9. Kennedy C.D., van Schalkwyk M.C., McKee M., Pisinger C. The cardiovascular effects of electronic cigarettes : a systematic review of experimental studies. Prev. Med. 2019; 127:105770. doi: 10.1016/j.ypmed.2019.105770
10. Khadka S., Awasthi M., Lamichhane R.R., Ojha C., Mamudu H.M., Lavie C.J., Daggubati R., Paul T.K. The cardiovascular effects of electronic cigarettes. Curr. Cardiol. Rep. 2021; 23(5):40. doi: ?10.1007/s11886-021-01469-4
11. Corless J.K., Middleton H.M. Normal liver function: a basis for understanding hepatic disease. Arch. Intern. Med. 1983; 143(12):2291–2294. doi: 10.1001/archinte.1983.00350120085018
12. Herrington J.S., Myers C. Electronic cigarette solutions and resultant aerosol profiles. J. Chromatogr. A 2015; 1418:192–199. doi: 10.1016/j.chroma.2015.09.034
13. Alshareef H.Z., Omaye S.T. Toxicology of commonly found ingredients in e-cigarettes: a brief review. Health 2021; 13(11):1396–1409. doi: 10.4236/health.2021.1311100
14. Hopstock K.S., Perraud V., Dalton A.B., Barletta B., Meinardi S., Weltman R.M., Mirkhanian M.A., Rakosi K.J., Blake D.R., Edwards R.D., Nizkorodov S.A. Chemical analysis of exhaled vape emissions: unraveling the complexities of humectant fragmentation in a human trial study. Chem. Res. Toxicol. 2024; 37(6):1000–1010. doi: 10.1021/acs.chemrestox.4c00088
15. Sun L., Luo C., Long J., Wei D., Liu J. Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion 2006; 6(3):136–142. doi: 10.1016/j.mito.2006.04.003
16. Mohammad M.K., Avila D., Zhang J., Barve S., Arteel G., McClain C., Joshi-Barve S. Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress. Toxicol. Appl. Pharmacol. 2012; 265(1):73–82. doi: 10.1016/j.taap.2012.09.021
17. Mello T., Ceni E., Surrenti C., Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol. Aspects Med. 2008; 29(1-2):17–21. doi: 10.1016/j.mam.2007.10.001
18. Setshedi M., Wands J.R., de la Monte S.M. Acetaldehyde adducts in alcoholic liver disease. Oxid. Med. Cell. Longev. 2010; 3(3):178–185. doi: 10.4161/oxim.3.3.12288
19. Chen W.Y., Zhang J., Ghare S., Barve S., McClain C., Joshi-Barve S. Acrolein is a pathogenic mediator of alcoholic liver disease and the scavenger hydralazine is protective in mice. Cell. Mol. Gastroenterol. Hepatol. 2016; 2(5):685–700. doi: 10.1016/j.jcmgh.2016.05.010
20. Cikmaz S., Kutoglu T., Kanter M., Mesut R. Effect of formaldehyde inhalation on rat livers: a light and electron microscopic study. Toxicol. Ind. Health 2010; 26(2):113–119. doi: 10.1177/0748233710362384
21. Zhang S., Chen H., Wang A., Liu Y., Hou H., Hu Q. Combined effects of co-exposure to formaldehyde and acrolein mixtures on cytotoxicity and genotoxicity in vitro. Environ. Sci. Pollut. Res. 2018; 25:25306–25314. doi: 10.1007/s11356-018-2584-z
22. Hernandez A., Sonavane M., Smith K.R., Seiger J., Migaud M.E., Gassman N.R. Dihydroxyacetone suppresses mTOR nutrient signaling and induces mitochondrial stress in liver cells. PLoS One 2022; 17(12):e0278516. doi: 10.1371/journal.pone.0278516
23. Rickard B.P., Ho H., Tiley J.B., Jaspers I., Brouwer K.L. E-cigarette flavoring chemicals induce cytotoxicity in HepG2 cells. ACS Omega 2021; 6(10):6708–6713. doi: 10.1021/acsomega.0c05639
24. Timkin P.D., Timofeev E.A., Borodin E.A. [TRPM8 ligand modification]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin of Physiology and Pathology of Respiration 2022; 84:32–36 (in Russian). doi: 10.36604/1998-5029-2022-84-32-36
25. El Golli N., Jrad-Lamine A., Neffati H., Rahali D., Dallagi Y., Dkhili H., Ba N., El May M.V., El Fazaa S. Impact of e-cigarette refill liquid with or without nicotine on liver function in adult rats. Toxicol. Mech. Methods. 2016; 26(6):433–440. doi: 10.3109/15376516.2016.1160963
26. Nima R.S., Aziz D.Z. The oxidative stress induced by the vapours of electronic-hookah on mice liver tissues. Sys. Rev. Pharm. 2020; 11(9):420–423. doi: 10.31838/srp.2020.9.59
27. Granata S., Canistro D., Vivarelli F., Morosini C., Rullo L., Mercatante D., Rodriguez-Estrada M.T., Baracca A., Sgarbi G., Solaini G., Ghini S., Fagiolino I., Sangiorgi S., Paolini M. Potential harm of IQOS smoke to rat liver. Int. J. Mol. Sci. 2023; 24(15):12462. doi: 10.3390/ijms241512462
28. Hasan K.M., Friedman T.C., Shao X., Parveen M., Sims C., Lee D.L., Espinoza-Derout J., Sinha-Hikim I., Sinha-Hikim A.P. E‐cigarettes and western diet: important metabolic risk factors for hepatic diseases. Hepatology 2019; 69(6):2442–2454. doi: 10.1002/hep.30512
29. Bekyarova G., Tzaneva M., Bratoeva K., Ivanova I., Kotzev A., Hristova M., Krastev D., Kindekov I., Mileva M. 4-Hydroxynonenal (HNE) and hepatic injury related to chronic oxidative stress. Biotechnol. Biotechnol. Equip. 2019; 33(1):1544–1552. doi: 10.1080/13102818.2019.1674690
30. Kanithi M., Junapudi S., Shah S.I., Reddy A.M., Ullah G., Chidipi B. Alterations of mitochondrial network by cigarette smoking and e-cigarette vaping. Cells 2022; 11(10):1688. doi: 10.3390/cells11101688
31. Espinoza-Derout J., Shao X.M., Bankole E., Hasan K.M., Mtume N., Liu Y., Sinha-Hikim A.P., Friedman T.C. Hepatic DNA damage induced by electronic cigarette exposure is associated with the modulation of NAD+/PARP1/SIRT1 axis. Front. Endocrinol. 2019; 10:320. doi: 10.3389/fendo.2019.00320
32. Li G., Chan Y.L., Wang B., Saad S., George J., Oliver B.G., Chen H. E‐cigarettes damage the liver and alter nutrient metabolism in pregnant mice and their offspring. Ann. N.Y. Acad. Sci. 2020; 1475(1):64–77. doi: 10.1111/nyas.14411
33. Wang Q., Ji X., Rahman I. Dysregulated metabolites serve as novel biomarkers for metabolic diseases caused by e-cigarette vaping and cigarette smoking. Metabolites 2021; 11(6):345. doi: 10.3390/metabo11060345
34. Aubrecht J., Schomaker S.J., Amacher D.E. Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury. Genome Med. 2013; 5:85. doi: 10.1186/gm489
35. Salman R.J., Alyodawi K. Biochemical and histopathological study of the toxic effects of electronic and conventional cigarette smoke on the liver of rats. IJST 2023; 2(5):7–15.
36. Abd Z.S., Mehdi W.T. Effects of vaping and water pipe on lipid profiles, glucose and liver enzymes. Central Asian Journal of Medical and Natural Science 2023; 4(3):582–591.
37. Mumtaz H., Hameed M., Sangah A.B., Zubair A., Hasan M. Association between smoking and non-alcoholic fatty liver disease in Southeast Asia. Front. Public Health 2022; 10:1008878. doi: 10.3389/fpubh.2022.1008878
38. Sinyakin I.A., Shestakova M.A., Byshlyaga O.Yu., Batalova T.A. [Main pathologic effects of exposure to highly dispersed e-cigarette aerosol on lung cells and respiratory epithelium : literature review]. Meditsina = Medicina 2024; 12(1):72–87 (in Russian). doi: 10.29234/2308-9113-2024-12-1-1-10
39. Chakinala R.C., Dawoodi S., Fabara S.P., Asad M., Khayyat A., Chandramohan S., Aslam A., Unachukwu N., Nasyrlaeva B., Jaiswal R., Chowdary S.B., Malik P., Rabbani R. Association of smoking and e-cigarette in chronic liver disease: an NHANES study. Gastroenterol. Res. 2022; 15(3):113– 119. doi: 10.14740/gr1490
40. Editorial Office. Retraction notice to "Association of smoking and e-cigarette in chronic liver disease: an NHANES study". Gastroenterol. Res. 2023; 16(3):201. doi: 10.14740/gr1490r
41. Fan T., DuBose L., Wayne C., Sisniega C. E-cigarette, or vaping, associated lung and hepatic injury. J. Pediatr. Gastroenterol. Nutr. 2020; 71(3):e98–e100. doi: 10.1097/MPG.0000000000002744
42. Godbee M., Jakate S., Eswaran S. A case of electronic nicotine delivery systems (ENDS) liver injury. Hepatology 2021; 73(3):1230–1232. doi: %10.1002/hep.31475
43. Van Roey G., Goos W., Claessens C., Hoorens A., Verlinden W., Schouten J. Acute grade IV toxic hepatitis due to the e-cigarette. Acta Gastroenterol. Belg. 2024; 87(1):44–47. doi: 10.51821/87.1.11378
Review
For citations:
Androsova O.G., Allazov D.R., Zinin M.S. Effects of electronic cigarettes on the liver (literature review). Bulletin Physiology and Pathology of Respiration. 2025;(96):154-163. (In Russ.) https://doi.org/10.36604/1998-5029-2025-96-154-163